KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marvell Technology (MRVL) Accumulated Expenses (2021 - 2026)

Marvell Technology (MRVL) has disclosed Accumulated Expenses for 6 consecutive years, with $1.3 billion as the latest value for Q1 2026.

  • Quarterly Accumulated Expenses rose 37.48% to $1.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Jan 2026, up 37.48% year-over-year, with the annual reading at $1.3 billion for FY2026, 37.48% up from the prior year.
  • Accumulated Expenses hit $1.3 billion in Q1 2026 for Marvell Technology, down from $1.4 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.4 billion in Q4 2025 to a low of $167.5 million in Q2 2024.
  • Historically, Accumulated Expenses has averaged $443.1 million across 5 years, with a median of $241.3 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: tumbled 75.94% in 2024 and later soared 398.74% in 2025.
  • Year by year, Accumulated Expenses stood at $248.3 million in 2022, then decreased by 1.33% to $245.0 million in 2023, then rose by 10.57% to $270.9 million in 2024, then skyrocketed by 398.74% to $1.4 billion in 2025, then fell by 1.04% to $1.3 billion in 2026.
  • Business Quant data shows Accumulated Expenses for MRVL at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $210.8 million in Q3 2025.